Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1119643/000139843216000687/a12966.htm
October 2018
September 2018
March 2018
November 2017
May 2017
April 2015
April 2015
September 2013
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1119643/000139843216000687/a12966.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Nutra Pharma Corp.
Nutra Pharma Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2016 10-K Annual Report includes:
Ticker: NPHCEvents:
CIK: 1119643
Form Type: 8-K Corporate News
Accession Number: 0001398432-16-000687
Submitted to the SEC: Tue Jul 26 2016 5:45:35 PM EST
Accepted by the SEC: Wed Jul 27 2016
Period: Thursday, July 21, 2016
Industry: Medicinal Chemicals And Botanical Products